Technology
Health
Biotechnology

Auris Medical

$2.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-1.85%) Today
+$0.05 (1.89%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Auris Medical and other stocks, options, ETFs, and crypto commission-free!

About EARS

Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurotology and central nervous system disorders. The firm focuses on the development of intranasal betahistine for the treatment of vertigo and for the prevention of antipsychotic-induced weight gain and somnolence. Read More It also includes other programs under development such as Keyzilen, for the treatment of acute inner ear tinnitus; and Sonsuvi, for the treatment of acute inner ear hearing loss. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.

Employees
11
Headquarters
Hamilton, Hamilton City
Founded
2003
Market Cap
4.79M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
58.04K
High Today
$2.82
Low Today
$2.62
Open Price
$2.73
Volume
58.09K
52 Week High
$39.40
52 Week Low
$2.41

Collections

Technology
Health
Biotechnology
Medical
2014 IPO

EARS Earnings

-$0.50
-$0.37
-$0.23
-$0.10
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Aug 15, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.